- Home
- ODD vs QDEL Comparison
ODD vs QDEL Comparison
Compare ODD & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ODD | QDEL |
|---|---|---|
| Founded | 2018 | 1979 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | ODD | QDEL |
|---|---|---|
| Price | $30.07 | $29.10 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 6 |
| Target Price | ★ $66.73 | $40.00 |
| AVG Volume (30 Days) | 996.1K | ★ 1.0M |
| Earning Date | 02-24-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.01 | N/A |
| EPS | ★ 1.79 | N/A |
| Revenue | $780,758,000.00 | ★ $2,714,400,000.00 |
| Revenue This Year | $26.15 | N/A |
| Revenue Next Year | $20.55 | $2.28 |
| P/E Ratio | $16.06 | ★ N/A |
| Revenue Growth | ★ 25.80 | N/A |
| 52 Week Low | $28.16 | $19.50 |
| 52 Week High | $79.18 | $44.68 |
Technical Indicators
Market Signals| Indicator | ODD | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 26.87 | 49.19 |
| Support Level | $28.16 | $26.50 |
| Resistance Level | $36.65 | $29.97 |
| Average True Range (ATR) | 1.61 | 1.72 |
| MACD | -0.34 | -0.17 |
| Stochastic Oscillator | 15.67 | 44.04 |
Price Performance
Historical ComparisonAbout ODD ODDITY Tech Ltd.
ODDITY Tech Ltd offers a consumer tech platform that is built to transform the beauty and wellness market. The ODDITY platform is designed to support a portfolio of brands and services that innovate and disrupt the expansive beauty and wellness market. It consumes user data to develop physical beauty and wellness products that deliver performance and functionality. Its brands include SpoiledChild and IL Makiage.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.